Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hyperion's Drug Ravicti Likely To Receive FDA Approval
Seeking Alpha
Wednesday, January 9, 2013 - 12:18pm
tags:
Hyperion, Ravicti, FDA, Vertex Pharmaceuticals
A House of Pain for Zogenix
Motley Fool
Wednesday, January 9, 2013 - 12:16pm
tags:
Zogenix, Zohydro ER
First Half Of 2013 To Be A Critical Time For Exact Sciences
Seeking Alpha
Wednesday, January 9, 2013 - 10:10am
tags:
EXACT Sciences, Sequenom, Illumina, Amarantus BioSciences, Cologuard
4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wednesday, January 9, 2013 - 10:06am
tags:
Vivus, Peregrine Pharmaceuticals, JNJ, Cellceutix
Vertex Refocuses Drug Development to Specialty Diseases
Bloomberg
Wednesday, January 9, 2013 - 10:03am
tags:
Vertex Pharmaceuticals, JPMHC 2013, Kalydeco, Incivek
JPMorgan Healthcare Conference Highlights: Regeneron Pharmaceuticals
Motley Fool
Wednesday, January 9, 2013 - 10:02am
tags:
Regeneron, JPMHC 2013
JPMorgan Healthcare Conference Highlights: Bristol-Myers Squibb
Motley Fool
Wednesday, January 9, 2013 - 10:01am
tags:
JPMHC 2013, Bristol-Myers Squibb
Will AbbVie's Drug Pipeline Cloud Its Growth Prospects?
Motley Fool
Wednesday, January 9, 2013 - 10:01am
tags:
AbbVie, Abbott, Eli Lilly, Merck, Pfizer
Former Merck Worker: I Was Fired Over My Age
Pharmalot
Wednesday, January 9, 2013 - 9:31am
tags:
Merck, age discrimination
Peregrine Recovers As Phase II Trial Is Salvaged
Seeking Alpha
Wednesday, January 9, 2013 - 9:31am
tags:
Peregrine Pharmaceuticals, bavituximab, non-small cell lung cancer
The Importance of Alimta
Motley Fool
Wednesday, January 9, 2013 - 8:38am
tags:
Alimta, Eli Lilly
Medicines Co near 5-year high after company says anti-clotting drug cangrelor worked in study
Yahoo/AP
Wednesday, January 9, 2013 - 8:36am
tags:
Cangrelor, Medicines Company
Cliff? What Cliff? Pharma Excels Despite Patent Expiries
Motley Fool
Wednesday, January 9, 2013 - 8:03am
tags:
patent cliff, patents, Eli Lilly, Merck, Pfizer, Teva
Amarin Plays To Some Empty Seats at J.P. Morgan Confab
TheStreet.com
Wednesday, January 9, 2013 - 8:00am
tags:
Amarin, JPMHC 2013, Vascepa
Theravance: Tempting To Investors As Well As Partners
Seeking Alpha
Wednesday, January 9, 2013 - 7:58am
tags:
GSK, Theravance
Ampio Stays Calm Ahead Of Further Developments
Seeking Alpha
Wednesday, January 9, 2013 - 7:57am
tags:
Ampio Pharmaceuticals
AbbVie sees no need for major acquisitions-CFO
Reuters
Wednesday, January 9, 2013 - 7:57am
tags:
M&A, AbbVie
Zimmer: We're not pushing the device tax down the line
Mass Device
Tuesday, January 8, 2013 - 11:13pm
tags:
Zimmer, device tax, devices
Interview: Medtronic CEO Ishrak on the road ahead
Mass Device
Tuesday, January 8, 2013 - 11:12pm
tags:
Medtronic, CEO
CardioKinetix targets FDA approval with heart-failure device trial
FierceMedicalDevice
Tuesday, January 8, 2013 - 11:09pm
tags:
CardioKinetix, FDA, heart, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.